Biomagnetics Diagnostics Corporation to Hold Rescheduled Investor Conference Call to Introduce World Class Biosensor Technology for Malaria, HIV and Tuberculosis Diagnosis

SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (Pink Sheets:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection will hold an investor conference call to discuss upcoming business opportunities and its agreement with Los Alamos National Security, one of the world’s premiere research laboratories.